Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma

AIM: There is an urgent need to establish biomarkers for the treatment of pancreatic ductal adenocarcinoma (PDAC). The aim of this study was to investigate the usefulness of the combined assessment of carbohydrate antigen 19‐9 (CA19‐9), carcinoembryonic antigen (CEA), and duke pancreatic monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Tadataka, Nagai, Minako, Nishiwada, Satoshi, Terai, Taichi, Yasuda, Satoshi, Matsuo, Yasuko, Doi, Shunsuke, Kohara, Yuichiro, Sho, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043775/
https://www.ncbi.nlm.nih.gov/pubmed/36998299
http://dx.doi.org/10.1002/ags3.12629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043775/
https://www.ncbi.nlm.nih.gov/pubmed/36998299
http://dx.doi.org/10.1002/ags3.12629

Ejemplares similares